Canada markets open in 4 hours 4 minutes

Aldeyra Therapeutics, Inc. (ALDX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.94000.0000 (0.00%)
At close: 04:00PM EDT
3.9400 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 234.09M
Enterprise Value 106.93M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.95
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -3.04

Trading Information

Stock Price History

Beta (5Y Monthly) 1.52
52-Week Change 3-58.66%
S&P500 52-Week Change 321.08%
52 Week High 311.9700
52 Week Low 31.4200
50-Day Moving Average 33.6328
200-Day Moving Average 34.4652

Share Statistics

Avg Vol (3 month) 3593.17k
Avg Vol (10 day) 3516.04k
Shares Outstanding 559.41M
Implied Shares Outstanding 659.41M
Float 842.78M
% Held by Insiders 11.99%
% Held by Institutions 161.60%
Shares Short (Apr 15, 2024) 42.36M
Short Ratio (Apr 15, 2024) 43.08
Short % of Float (Apr 15, 2024) 44.79%
Short % of Shares Outstanding (Apr 15, 2024) 43.97%
Shares Short (prior month Mar 15, 2024) 41.83M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-16.23%
Return on Equity (ttm)-27.73%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -42.53M
Net Income Avi to Common (ttm)-37.54M
Diluted EPS (ttm)-0.6400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)142.82M
Total Cash Per Share (mrq)2.42
Total Debt (mrq)15.66M
Total Debt/Equity (mrq)13.07%
Current Ratio (mrq)6.64
Book Value Per Share (mrq)2.02

Cash Flow Statement

Operating Cash Flow (ttm)-30.33M
Levered Free Cash Flow (ttm)-27.62M